134 related articles for article (PubMed ID: 12623225)
1. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain.
Allen KV; McGregor IS; Hunt GE; Singh ME; Mallet PE
Neuropharmacology; 2003 Feb; 44(2):264-74. PubMed ID: 12623225
[TBL] [Abstract][Full Text] [Related]
2. Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716.
Singh ME; Verty AN; Price I; McGregor IS; Mallet PE
Neuropharmacology; 2004 Dec; 47(8):1157-69. PubMed ID: 15567425
[TBL] [Abstract][Full Text] [Related]
3. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain.
Buller KM; Hamlin AS; Osborne PB
Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445
[TBL] [Abstract][Full Text] [Related]
4. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic nicotine exposure on Δ
Miladinovic T; Manwell LA; Raaphorst E; Malecki SL; Rana SA; Mallet PE
Pharmacol Biochem Behav; 2020 Jul; 194():172931. PubMed ID: 32353393
[TBL] [Abstract][Full Text] [Related]
6. Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropsychopharmacology; 2006 Jan; 31(1):58-69. PubMed ID: 15920503
[TBL] [Abstract][Full Text] [Related]
7. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain.
Arnold JC; Topple AN; Mallet PE; Hunt GE; McGregor IS
Brain Res; 2001 Dec; 921(1-2):240-55. PubMed ID: 11720732
[TBL] [Abstract][Full Text] [Related]
8. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain.
McGregor IS; Arnold JC; Weber MF; Topple AN; Hunt GE
Brain Res; 1998 Aug; 802(1-2):19-26. PubMed ID: 9748483
[TBL] [Abstract][Full Text] [Related]
9. Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain.
Porcella A; Gessa GL; Pani L
Eur J Neurosci; 1998 May; 10(5):1743-51. PubMed ID: 9751146
[TBL] [Abstract][Full Text] [Related]
10. c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal.
Veinante P; Stoeckel ME; Lasbennes F; Freund-Mercier MJ
Eur J Neurosci; 2003 Sep; 18(5):1295-305. PubMed ID: 12956728
[TBL] [Abstract][Full Text] [Related]
11. Roles of dopamine D1 receptors in delta 9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain.
Miyamoto A; Yamamoto T; Ohno M; Watanabe S; Tanaka H; Morimoto S; Shoyama Y
Brain Res; 1996 Feb; 710(1-2):234-40. PubMed ID: 8963664
[TBL] [Abstract][Full Text] [Related]
12. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
Manzanares J; Corchero J; Fuentes JA
Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
[TBL] [Abstract][Full Text] [Related]
13. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.
Solinas M; Zangen A; Thiriet N; Goldberg SR
Eur J Neurosci; 2004 Jun; 19(12):3183-92. PubMed ID: 15217374
[TBL] [Abstract][Full Text] [Related]
14. Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine.
Williams CM; Kirkham TC
Pharmacol Biochem Behav; 2002; 71(1-2):333-40. PubMed ID: 11812541
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.
Boucher AA; Hunt GE; Karl T; Micheau J; McGregor IS; Arnold JC
Neuroscience; 2007 Nov; 149(4):861-70. PubMed ID: 17905522
[TBL] [Abstract][Full Text] [Related]
16. Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice.
Balerio GN; Aso E; Berrendero F; Murtra P; Maldonado R
Eur J Neurosci; 2004 Nov; 20(10):2737-48. PubMed ID: 15548217
[TBL] [Abstract][Full Text] [Related]
17. Sucrose consumption increases naloxone-induced c-Fos immunoreactivity in limbic forebrain.
Pomonis JD; Jewett DC; Kotz CM; Briggs JE; Billington CJ; Levine AS
Am J Physiol Regul Integr Comp Physiol; 2000 Mar; 278(3):R712-9. PubMed ID: 10712293
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
[TBL] [Abstract][Full Text] [Related]
20. Fos immunoreactivity in the rat brain following consummatory elements of sexual behavior: a sex comparison.
Coolen LM; Peters HJ; Veening JG
Brain Res; 1996 Oct; 738(1):67-82. PubMed ID: 8949929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
